QUBIS — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Dia Beta Labs is a drug discovery and development company focused on diabetes and obesity research.
BiotechDigital HealthHealthtechLongevityMedical DevicesBelfast, GB
Dr. Ryan Lafferty(Founder, CEO)Prof. Peter Simpson(Executive Chair, Co-Founder)Prof. Nigel Irwin(Academic Director, Co-Founder)Prof. Peter Flatt(Scientific Committee, Co-Founder)Prof. Finbarr O'Harte(Scientific Committee, Co-Founder)Prof. Victor Gault(Scientific Committee, Co-Founder)
Co-investorsDSW VenturesClarendon Fund Managers Ltd.Innovate UKInnovation UlsterInvest Northern Ireland
Amply is a store operations platform that moves daily retail workflows from paper and spreadsheets into a single app, offering task checklists, scheduled SOPs, digital store visit audits, a communication feed, and AI-powered image verification for visual merchandising.
AI & Machine LearningRetail TechSaaS
Anshul Goyal(Founder)in
Co-investorsIIMA VenturesBritish Business BankClarendon Fund Managers Ltd.TechstarsTwin Path Venturesventure / science
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.